BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25952485)

  • 1. Optimal post-treatment surveillance in cancer survivors: is more really better?
    Shah M; Denlinger CS
    Oncology (Williston Park); 2015 Apr; 29(4):230-40. PubMed ID: 25952485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise in cancer survivors: an overview of research.
    Courneya KS
    Med Sci Sports Exerc; 2003 Nov; 35(11):1846-52. PubMed ID: 14600549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caring for the life you saved.
    Beck AC; Mooney K
    Oncology (Williston Park); 2015 Apr; 29(4):240-8. PubMed ID: 25952486
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance approaches among colorectal cancer survivors after curative-intent.
    Haggstrom DA; Imperiale TF
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):483-500. PubMed ID: 19942831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance and monitoring of adult cancer survivors.
    Choi M; Craft B; Geraci SA
    Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surviving surveillance.
    Sweetenham JW
    Oncology (Williston Park); 2015 Apr; 29(4):228. PubMed ID: 25952484
    [No Abstract]   [Full Text] [Related]  

  • 8. Costs of different follow-up strategies in early breast cancer: a review of the literature.
    van Hezewijk M; van den Akker ME; van de Velde CJ; Scholten AN; Hille ET
    Breast; 2012 Dec; 21(6):693-700. PubMed ID: 23084960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up care for cancer: making the benefits equal the cost.
    Schwartz D; Billingsley K; Wallner K
    Oncology (Williston Park); 2000 Oct; 14(10):1493-8, 1501; discussion 1502-5. PubMed ID: 11098513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
    Blanchard CM; Courneya KS; Stein K;
    J Clin Oncol; 2008 May; 26(13):2198-204. PubMed ID: 18445845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
    Soneji S; Yang J
    Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    Zheng Z; Yabroff KR; Guy GP; Han X; Li C; Banegas MP; Ekwueme DU; Jemal A
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26705361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.
    Meyerhardt JA; Mangu PB; Flynn PJ; Korde L; Loprinzi CL; Minsky BD; Petrelli NJ; Ryan K; Schrag DH; Wong SL; Benson AB;
    J Clin Oncol; 2013 Dec; 31(35):4465-70. PubMed ID: 24220554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.
    Gatta G; Trama A; Capocaccia R
    J Natl Cancer Inst Monogr; 2013; 2013(46):79-87. PubMed ID: 23962511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance for prostate cancer: progress and promise.
    Cooperberg MR; Carroll PR; Klotz L
    J Clin Oncol; 2011 Sep; 29(27):3669-76. PubMed ID: 21825257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
    Dahlhaus A; Semlitsch T; Jeitler K; Horvath K; Siebenhofer A
    Fam Pract; 2015 Oct; 32(5):483-91. PubMed ID: 26142418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
    Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
    Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic disparities in treatment costs among ambulatory Medicaid cancer patients.
    Mullins CD; Snyder SE; Wang J; Cooke JL; Baquet C
    J Natl Med Assoc; 2004 Dec; 96(12):1565-74. PubMed ID: 15622686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.